Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
Pedro L. Moro, Bicheng Zhang, Carol Ennulat, Margaret Harris, Rachel McVey, Gina Woody, Paige Marquez, Michael M. McNeil, John R. Su
Topics & Concepts
Adverse Event Reporting SystemVirologyCoronavirus disease 2019 (COVID-19)Seasonal influenza2019-20 coronavirus outbreakAdministration (probate law)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineAdverse effectInfluenza vaccineLive attenuated influenza vaccineVaccinationPharmacologyOutbreakInternal medicinePolitical scienceInfectious disease (medical specialty)LawDiseaseSARS-CoV-2 and COVID-19 ResearchIntramuscular injections and effectsLymphadenopathy Diagnosis and Analysis